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Abstract: African Americans (AA) tend to have heightened systemic inflammation and 
endothelial dysfunction. Endothelial microparticles (EMP) are released from activated/apoptotic 
endothelial cells (EC) when stimulated by inflammation. The purpose of our study was to assess 
EMP responses to inflammatory cytokine (TNF-α) and antioxidant (superoxide dismutase, 
SOD) conditions in human umbilical vein ECs (HUVECs) obtained from AA and Caucasians. 
EMPs were measured under four conditions: control (basal), TNF-α, SOD, and TNF-α + SOD. 
  Culture supernatant was collected for EMP analysis by flow cytometry and IL-6 assay by ELISA. 
IL-6 protein expression was assessed by Western blot. AA HUVECs had greater EMP levels 
under the TNF-α condition compared to the Caucasian HUVECs (6.8 ± 1.1 vs 4.7% ± 0.4%, 
P = 0.04). The EMP level increased by 89% from basal levels in the AA HUVECs under the 
TNF-α condition (P = 0.01) compared to an 8% increase in the Caucasian HUVECs (P = 0.70). 
Compared to the EMP level under the TNF-α condition, the EMP level in the AA HUVECs 
was lower under the SOD only condition (2.9% ± 0.3%, P = 0.005) and under the TNF-α + 
SOD condition (2.1% ± 0.4%, P = 0.001). Basal IL-6 concentrations were 56.1 ± 8.8 pg/mL/µg 
in the AA and 30.9 ± 14.9 pg/mL/µg in the Caucasian HUVECs (P = 0.17), while basal IL-6 
protein expression was significantly greater (P , 0.05) in the AA HUVECs. These preliminary 
observational results suggest that AA HUVECs may be more susceptible to the injurious effects 
of the proinflammatory cytokine, TNF-α.
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Introduction
Endothelial dysfunction precedes hypertension and atherosclerosis1,2 and is a prog-
nostic indicator of future cardiovascular events. In response to sensing hormonal, 
biochemical, and mechanical stimuli, the endothelium releases mediators of vascular 
function, initiates inflammatory processes, and influences homeostasis. In the US, 
African Americans experience higher mortality from cardiovascular disease (CVD) 
including hypertension compared to Caucasians or Mexican Americans.3
An impaired endothelium is conventionally thought to be analogous to diminished 
nitric oxide (NO)-mediated vasodilation in response to endothelial NO synthase 
(eNOS) agonists such as acetylcholine or bradykinin. Currently, there is an expanded 
appreciation of endothelial dysfunction which includes a proinflammatory, pro-oxidant, 
and prothrombic EC state. Several studies have shown that African-Americans have 
impaired endothelial function as determined by flow-mediated dilation (FMD)4–6 and 
other measures of endothelial-dependent vasodilation.7–12
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The mechanisms underlying racial disparities in CVD and 
endothelial dysfunction are multifactorial, but could be due, 
in part, to differences in endothelial cell (EC) responses to 
stimuli. However, a major problem with research on the racial 
disparity in endothelial dysfunction is that it is conducted 
at the organ or clinical levels and not at the cellular level. 
This lack of knowledge about the EC biology of African 
Americans severely impedes advances in finding optimal 
preventive and treatment strategies.
In response to proinflammatory cytokine stimulation, 
ECs undergo functional changes that include increased 
expression/production of IL-6 and adhesion molecules, and 
induction of procoagulant activity.13–15 African Americans 
have also been shown to have higher levels of inflammatory 
markers compared to Caucasians and this also may   contribute 
to the greater CVD-related morbidity and mortality in this 
population.16–21 Studies have linked inflammation to EC 
activation, an early step in endothelial dysfunction, and loss 
of NO bioactivity.22 In a cell culture study, Kalinowski et al 
showed that human umbilical ECs (HUVECs) from African 
Americans had reduced NO bioavailability compared to 
Caucasian HUVECs primarily due to increased superoxide 
(O2
-) production and eNOS uncoupling.23
Endothelial microparticles (EMP) are submicroscopic 
membranous particles that are released from activated or 
apoptotic parent EC when stimulated by proinflammatory 
cytokines, oxidative stress, or infectious agents.24 They carry 
with them a subset of membrane proteins and phospholipids, 
or markers, of their parent EC including those induced by 
activation, apoptosis or oxidative stress. Recent evidence 
indicates that EMPs provide valuable information about the 
biological status of the endothelium. Previous studies have 
shown that EMPs expressing constitutive surface markers 
such as CD31 (platelet endothelial cell adhesion molecule; 
PECAM) are increased in injury and/or apoptosis.25 Results 
from both clinical and laboratory studies demonstrate that 
higher EMP levels are related to diminished endothelium-
dependent vasodilation. The level of EMP appears to cor-
relate with the degree of endothelial dysfunction in patients 
with chronic renal failure26 or coronary artery disease.27 Thus, 
the level of EMPs is emerging as a novel direct marker of 
EC impairment mediated by activation and apoptosis28,29 
and may provide new insight into the mechanisms of racial 
disparities in endothelial dysfunction. However, EMPs have 
never been used to assess potential racial differences in 
endothelial function.
Due to the hypothesized mechanisms leading to endothe-
lial dysfunction and EC impairment in African Americans, 
the purpose of our study was to observe EMP responses to 
inflammatory cytokine (TNF-α) and antioxidant   (superoxide 
dismutase, SOD) conditions in HUVECs obtained from 
African Americans and Caucasians.
Methods
Human umbilical vein endothelial cells
HUVECs were purchased from Lonza Inc (Walkersville, 
MD), who harvested ECs from umbilical cord donors (AA, 
n = 3; Caucasian, n = 3). Cryopreserved HUVECs were then 
shipped by Lonza as frozen primaries. The HUVECs were 
cultured in parallel, in EGM medium supplemented with 2% 
fetal bovine serum (FBS) and growth factors (Lonza, Inc) at 
37°C in a 95% air -5% CO2 atmosphere, following methods 
by Lonza. All Lonza HUVECs are characterized by morpho-
logical observation through serial passaging, positive test 
for von Willebrand Factor VIII and acetylated low density 
lipoprotein (LDL) uptake, and negative test for α-smooth 
muscle actin.
experimental procedures
Human recombinant TNF-α was purchased from Sigma 
(St Louis, MO) and SOD was purchased from   Worthington 
Biochemical Corporation (Lakewood, NJ). Parallel HUVEC 
cultures were tested under four separate conditions:   Control, 
TNF-α (100 U/mL) for 4 hours, SOD (100 U/mL) for 
24 hours, and TNF-α + SOD. 100 U/mL of TNF-α was 
selected because it is a typical level used to stimulate ECs 
and falls approximately midway between the highest and 
lowest levels used to stimulate ECs in similar studies.30–35 
Culture media samples (4 mL) obtained from 106 ECs were 
collected and immediately frozen at -80°C for subsequent 
EMP analysis.25,36 Remaining culture supernatant was col-
lected for IL-6 assay.
Cell lysate was collected by cellular fractionation for total 
SOD activity measurements. Briefly, cells were washed once 
with ice-cold phosphate buffer solution, and resuspended in 
2 mL cold 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) buffer (Lonza) using a rubber scraper. Cells 
were centrifuged at 600g for 10 minutes at 4°C. The cell pel-
let was resuspended in 500 µL cold HEPES buffer and then 
transferred to a Teflon glass homogenizer. The cell solution 
was homogenized at 1600 rpm for 30 strokes while on ice, 
and then immediately centrifuged at 1500g for 5 minutes at 
4°C. Protein concentration was measured using the Bradford 
method.
For all procedures, AA and Caucasian HUVECs at 
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samples were tested in duplicate and control samples of 
culture media were tested along with the cell samples in 
order to eliminate potential interference from culture media 
in measurements. Absorbance was read using a SpectraMax 
Microplate Reader (Molecular Devices, Sunnyvale, CA).
eMP immunolabeling
Microparticles express several different cell surface markers 
which can be quantified. The preferred method is the 2-color 
combination of phycoerythrin (PE)-labeled anti-CD31 
with fluorescein isothiocyanate (FITC)-labeled anti-CD42. 
Because CD31 is also found on platelets, platelet-specific 
CD42 allows counting the platelet microparticles popula-
tion (CD31+, CD42+) distinct from EMP (CD31+, CD42-), 
giving both counts in a single run. This pair of markers has 
the advantage of being very bright and therefore sensitive.29 
EMP samples were prepared as previously described.37,38
To remove unwanted cellular fragments, thawed culture 
media (1.5 mL) was centrifuged for 5 minutes at 4300g 
(20°C). Supernatant was removed and transferred into a new 
tube and centrifuged for 90 minutes at 3152g (20°C). 100 µL 
of the supernatant was transferred to a new tube and incubated 
with 20 µL of anti-human CD31+ (PE) and 20 µL of anti 
CD42 (FITC) in the dark at room temperature (30 minutes), 
then fixed by adding 93 µL of 10% formaldehyde. The 
mixture was protected from light and incubated while being 
gently mixed for 20 minutes using a shaker. Samples were 
diluted in 500 µL of double-filtered (0.22 µm) PBS for a 
total sample volume of 733 µL. Two additional tubes were 
prepared to serve as a negative control and as a calibration. 
For the negative control tube, 733 µL of PBS was added to one 
tube. To prepare the calibrator sample, two drops of 0.9 µm 
standard precision NIST traceable polystyrene particle beads 
  (Polysciences Inc, Warrington PA) were added to PBS accord-
ing to the manufacturer’s instructions. All samples were then 
immediately analyzed by flow cytometry.
Flow cytometry
Labeled EMP produced by 106 ECs were analyzed using an 
LSRII flow cytometer (BD Biosciences, San Jose, CA) and ana-
lyzed with BD FACSDiva software (v 1.2.6; BD Biosciences). 
There is no consensus on the threshold level setting which deter-
mines the smallest size microparticle analyzed, therefore we set 
the threshold levels based on the number of background events 
per second when double-filtered PBS was passed through the 
flow cytometer as reported by Orozco and Lewis.39 The upper 
limit of gate was determined by 0.9 µm standard beads. CD31+/
C42- events included in this gate were identified in forward and 
side scatter intensity dot representation and plotted on 2-color 
fluorescence histograms and were considered EMP.5,40,41–43 
From each 50 µL sample, the percentage of EMP from 50,000 
total events was recorded.40,41 Before every run, the machine 
was kept running until the background events fell to baseline 
levels. The final EMP values were then expressed as % total 
events40 normalized to protein content (µg/µL). The inter- and 
intra-assay CVs were 8% and 6%, respectively.
Western blot for iL-6 protein
HUVECs were washed twice in ice-cold Hanks buffered 
saline solution and lysed in Radio-Immunoprecipitation 
Assay Buffer with Roche protease inhibitor (RIPA-Pi). 
  Phenylmethylsulfonyl fluoride protease inhibitor was also 
added to the RIPA-Pi to eliminate interference. At con-
fluence, cells were collected, centrifuged at 16,000g for 
10 minutes at 4°C. Quantification of protein content was 
measured by Bradford assay. 20 µg of protein was sepa-
rated by electrophoresis through 10% SDS-polyacrylamide 
gel. Proteins were then transferred to nitrocellulose filter 
  membranes. Membranes were blocked with non-fat dry milk 
in Tris-buffered saline and incubated overnight with primary 
antibodies at 4°C. Subsequently, the membranes were washed 
and then incubated with secondary antibody conjugated 
with horseradish peroxidase. Immunoreactive proteins were 
detected by chemiluminescence with Thermo Scientific 
SuperSignal substrate systems (Pierce   Biotechnology). 
Anti-IL-6 (Abcam, Inc, MA). Actin antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA) was used as the internal 
control. Band densitometry analysis was performed using 
National Institutes of Health ImageJ software.
Assay for superoxide dismutase  
(sOD) activity
Total SOD activity was measured in order to have an assess-
ment of the cell’s potential for superoxide quenching. Total 
SOD activity in cell lysate samples by assay (Cayman Chemi-
cal, Ann Arbor, MI), as previously reported.42 Concentrations 
were normalized to protein content (µg/µL). Inter-assay and 
intra-assay CVs were 5.9% and 12.4%, respectively.
Assay for iL-6
IL-6 proteins released into media were measured in cell 
culture supernatants by ELISA (Thermo Scientific-Pierce 
Biotechnology, Rockford, IL), according to manufacturer’s 
instructions. Concentrations were normalized to protein 
content (µg/µL). The intra- and inter-assay CVs were 9% 
and 10%, respectively.Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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statistical analysis
All values were presented as means ± SE. Two-way 
(ethnicity by condition) and one-way (within ethnicity and 
within experimental condition) ANOVA followed by Fisher’s 
protected least significant difference (PLSD) were performed 
for statistical comparisons. An independent t-test was used 
to compare band densities for IL-6 expression between AA 
and Caucasian HUVECs. A P-value ,0.05 was considered 
statistically significant.
Results
HUVec morphology under  
all experimental conditions
Representative images of AA and Caucasian HUVECs at 
confluency under all experimental conditions are shown 
in Figure 1. HUVECs displayed a cobblestone-like shape. 
There were no morphological differences between the AA 
and Caucasian HUVECs.
eMP levels under basal conditions
Figure 2 shows comparisons of EMP levels between AA 
and Caucasian HUVECs under all experimental conditions. 
Control
African 
American Caucasian Experimental
condition
TNF-α
SOD
TNF-α + SOD
Figure 1 Representative images of African American and caucasian HUVecs at 
harvest under all experimental conditions.
Abbreviations: HUVec, human umbilical vein endothelial cells; sOD, superoxide 
dismutase; TnF-α, tissue necrosis factor alpha.
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Figure 2 comparison of eMP levels between the African American and caucasian 
HUVec groups under each of the experimental conditions.
Note: *P , 0.05 between HUVec racial groups.
Abbreviations: HUVec, human umbilical vein endothelial cells; sOD, superoxide 
dismutase, eMP, endothelial microparticles; AnOVA, analysis of variance.
There were no significant differences in EMP levels under 
basal conditions between AA (3.6% ± 0.7%) and Caucasian 
(4.4% ± 0.6%) HUVECs (P = 0.38).
effects of TnF-α stimulation  
and sOD on eMP generation
TNF-α is a potent inducer of inflammatory reactions and 
oxidative stress in EC. When the levels of EMPs were ana-
lyzed by experimental condition (AA and Caucasian HUVEC 
responses combined), TNF-α significantly increased EMP 
from the basal level of 3.9% ± 0.4% to 5.7% ± 0.6% (P = 0.01). 
Compared to the basal EMP level, SOD decreased the EMP 
level to 3.0% ± 0.5% (P = 0.19). Compared to the TNF-α 
condition, the addition of SOD significantly reduced the 
EMP level to 3.0 ± 0.3 (P , 0.0001). The EMP levels under 
the SOD only condition (3.0 ± 0.3) and the TNF-α + SOD 
condition (2.6 ± 0.3) were not different.
The interactive effect of HUVEC race and experimental 
condition was borderline significant (P = 0.06, Figure 2). Post 
hoc analyses showed that AA HUVECs had a significantly 
greater level of EMP under the TNF-α condition compared to 
the Caucasian HUVECs (6.8 ± 1.1 vs 4.7% ± 0.4%, P = 0.04). 
Within the AA HUVECs, the EMP level increased by 89% 
from a basal level of 3.5 ± 0.7 to 6.8% ± 1.1% under the TNF-α 
condition (P = 0.01) (Figure 3A). Compared to the EMP level 
under the TNF-α condition, the EMP level was significantly 
lower under the SOD only condition (2.9% ± 0.3%, P = 0.005) 
and under the TNF-α + SOD condition (2.1% ± 0.4%, 
P = 0.001). Within the Caucasian HUVECs, there was only 
an 8% increase in the EMP level from the basal condition to Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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caused a significant increase in SOD activity in the AA 
HUVECs (P = 0.04), while no significant change occurred 
with TNF-α stimulation in Caucasian HUVECs (P = 0.09).
iL-6 concentrations under  
basal conditions
IL-6 concentrations in AA and Caucasian HUVECs under 
all experimental conditions are shown in Figure 5. Basal 
IL-6 concentrations were (56.1 ± 8.8 pg/mL/µg) in the 
AA HUVECs and (30.9 ± 14.9 pg/mL/µg) the Caucasian 
HUVECs (P = 0.17). Given the nearly two-fold higher basal 
IL-6 concentration in the AA HUVECs, we wanted to confirm 
whether IL-6 protein expression was greater. Representa-
tive Western blots for IL-6 protein under basal conditions 
are shown in Figure 5. Basal IL-6 protein expression was 
significantly greater in the AA HUVECs compared to the 
Caucasian HUVECs. This confirmed the greater basal IL-6 
concentrations in the culture media of AA HUVECs.
effects of TnF-α stimulation and sOD on 
iL-6 concentrations and protein expression
The binding of TNF-α to its receptor on EC induces down-
stream gene expression of IL-6, which can influence EC 
function and cause increased adhesion and chemokine 
expression and apoptosis. When the levels of IL-6 were 
analyzed by experimental condition (AA and Caucasian 
HUVEC responses combined), IL-6 concentration increased 
from 44.9 ± 8.8 pg/mL/µg protein under basal conditions 
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Figure 3 A) eMP levels under each of the experimental conditions in African 
American HUVecs. B) eMP levels under each of the experimental conditions in 
caucasian HUVecs.
Abbreviations: HUVec, human umbilical vein endothelial cells; sOD, superoxide 
dismutase, eMP, endothelial microparticles.
the TNF-α condition (P = 0.70) (Figure 3B). The only sig-
nificant difference in EMP levels in the Caucasian HUVECs 
was between the TNF-α (4.7% ± 0.4%) and the TNF-α + SOD 
condition (3.0% ± 0.3%, P = 0.02). The difference in the level 
of EMP between the TNF-α condition (4.7 ± 0.4) and the SOD 
condition (3.2 ± 1.0) was borderline significant (P = 0.05).
Total sOD activity under basal  
and TnF-α conditions
Total SOD activity in AA and Caucasian HUVECs under 
basal and TNF-α conditions are shown in Figure 4. Basal 
SOD activity levels were (17.2 ± 12.0 U/mg) in the AA 
HUVECs and (35.8 ± 17.2 U/mg) the Caucasian HUVECs 
(P = 0.03). Compared to the basal levels, TNF-α   stimulation 
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Figure 4 Total sOD activity under basal and TnF-α conditions in African American 
and caucasian HUVecs.
Notes: * P  ,  0.05  between  HUVec  racial  groups  within  condition;  †P  ,  0.05 
compared to TnF-α condition within racial HUVec groups.
Abbreviations: HUVec, human umbilical vein endothelial cells; sOD, superoxide 
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to 62.6 ± 10.6 pg/mL/µg protein under TNF-α stimulation, 
but the difference was not statistically significant (P = 0.14). 
There were no significant differences in IL-6 concentrations 
between any of the other conditions. The interactive effect of 
HUVEC race and condition was not statistically significant 
(P = 0.43) (Figure 5). Within the AA HUVECs, the IL-6 con-
centration under the SOD condition tended to lower compared 
to the TNF-α condition (40.0 ± 8.0 vs 70.8 ± 15.7 pg/mL/µg, 
P = 0.07) (Figure 5). Within the Caucasian HUVECs, there 
were no significant differences in IL-6 concentrations between 
any of the experimental conditions (Figure 4).
Discussion
The most important finding of this preliminary observa-
tional study was that for the first time we showed that 
TNF-α-stimulated EMP generation was different between 
African American and Caucasian HUVECs. AA HUVECs 
demonstrated an 89% increase in EMP generation as a 
result of TNF-α stimulation compared to an 8% increase 
in EMP generation in the Caucasian HUVECS. This find-
ing is important because it is generally thought that for any 
given level of BP, African Americans have a greater degree 
of endothelial dysfunction compared to Caucasians and 
because the   measurement of the EMP expression of marker 
CD31 is linked to EC activation/apoptosis. Therefore, these 
  observations suggest that AA HUVECs have greater EC 
damage from TNF-α stimulation.
Microparticles are not released randomly into the 
  circulation.43 Activation or injury of the endothelium leads 
to various inflammatory-related processes including the 
release of microparticles. Combes et al were the first to 
demonstrate that HUVECs release EMP when stimulated 
with TNF-α.24 Other proinflammatory, prothrombotic, 
proapoptotic, or oxidative substances also induce the release 
of EMP.28,44 EMP express adhesion molecules specific for 
mature ECs such as CD54 (ICAM-1), CD62E (E-selectin), 
CD62P (P-selectin), or CD31 (PECAM).28,29 CD31 is also 
expressed by platelet-derived microparticles, therefore EMP 
specificity is ensured by the CD31+/CD41- phenotype with 
CD41 being the platelet integrin GPIIbIIIa.28,29 Studies have 
demonstrated that EMP can be used as a novel biomarker of 
endothelial injury that directly reflects the homeostatic state 
of the endothelium.29,45–49 To our knowledge, no study has 
used EMPs as an index of endothelial cell status to assess 
potential racial differences in EC function.
TNF-α stimulation caused a significant 89% increase 
in EMP level in AA HUVECs and a nonsignificant 8% 
increase in EMP level in the Caucasian HUVECs. The EMP 
levels under TNF-α stimulation were significantly differ-
ent between the HUVEC groups. Based on these results, 
it appears that AA HUVECs were more susceptible to the 
damaging effects of TNF-α. Plasma TNF-α concentrations 
have been associated with early atherosclerosis.50 Moreover, 
there are reports that African Americans have higher sys-
temic levels of inflammatory biomarkers16–21 which suggests 
that at least a portion of their endothelial dysfunction may 
be secondary to cytokine-induced endothelial activation/
apoptosis.
The endothelium has several important functions related 
to cardiovascular health. Functional changes of the activated 
endothelium include disturbance of the regulation of vessel 
tone and the maintenance of a vascular environment that 
favors coagulation, inflammation, and atherosclerosis. EMP 
levels are increased in hypertension and a significant corre-
lation was shown between EMP and blood pressure.46 It is 
thought that African Americans have lower endothelial NO 
bioavailability than Caucasians based on findings of attenu-
ated flow-mediated arterial vasodilatation.4–6 Other investi-
gations have also documented lower endothelial-dependent 
vasodilation in African Americans.8–11,51,52
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TNF-α can induce endothelial dysfunction through both 
inflammatory and oxidative stress mechanisms. TNF-α 
activates the p38 MAPK pathway53 and the transcription 
factor, NF-κB, which regulates the expression of genes 
involved in inflammation, oxidative stress, and endothelial 
dysfunction.54–56 Inflammatory cytokines induce the expres-
sion of adhesion molecules and chemoattractants by ECs. 
Gertzberg et al and Yamagishi et al showed that in response 
to TNF-α, EC NADPH oxidase activity increased, leading 
to increased O2
- production.57,58 Under normal physiological 
conditions, the dismutation of O2
- by SOD yields H2O2. In the 
case of heightened NADPH oxidase activity and O2
- overpro-
duction, O2
- reacts with NO to produce ONOO- thus reduc-
ing NO bioavailability.59 In order to assess the potential for 
O2
- dismutation in the present study, total SOD activity was 
measured in cell lysate from both basal and TNF-α stimulated 
AA and Caucasian HUVECs. We observed significantly 
higher SOD activity in the Caucasian HUVECs under both 
conditions. The AA HUVECs had a 79% increase in SOD 
activity compared to a 50% increase in Caucasian HUVECs. 
This could suggest a higher oxidative stress response to the 
TNF-α stimulation which is also evidenced by the height-
ened EMP production with TNF-α stimulation in the African 
American HUVECs.
In the present study, we also measured EMP levels after 
incubation of the HUVECs with SOD alone and after incu-
bation with TNF-α + SOD. The response to SOD alone was 
similar in both groups of HUVECs. Though both the AA and 
Caucasian HUVECs showed a significant decrease in EMP 
levels when the TNF-α + SOD condition was compared to 
the TNF-α alone condition, the AA HUVECs showed a 68% 
decrease in EMP levels whereas the Caucasian HUVECs 
showed a 35% decrease in EMP level. These results suggest 
that TNF-α-induced oxidative stress played a greater role in 
EMP generation in AA compared to Caucasian HUVECs 
because the effect of SOD was nearly twice that of the 
  Caucasian HUVECs.
The proinflammatory cytokine TNF-α also induces 
EC gene expression and production of IL-6 via the NF-κB 
  pathway.58 IL-6 is a secondary inflammatory cytokine that 
mediates the regulation of the acute-phase response to injury 
and infection. IL-6 induces the increase of plasma concen-
trations of fibrinogen, PAI-1, and CRP. Evidence indicates 
that the elevation of CRP predicts future cardiovascular 
events.60
In the present study, we observed that the AA HUVECs 
had nearly a two-fold greater basal IL-6 concentration 
compared to the Caucasian HUVECs. Western blot analy-
sis of basal IL-6 expression showed that the AA HUVECs 
had significantly greater IL-6 protein expression. The IL-6 
response to SOD was also different between the HUVEC 
groups. SOD decreased IL-6 concentration in the AA 
HUVECs but increased IL-6 concentration in the Caucasian 
HUVECs. The reasons for the disparate IL-6 response to SOD 
are not clear. Incubating the HUVECs with TNF-α + SOD 
similarly decreased IL-6 concentrations compared to incuba-
tion with TNF-α alone. These changes were similar in both 
HUVEC groups. In healthy men, elevated levels of IL-6 were 
associated with increased future CVD risk, endothelial dys-
function, and hypertension.61–63 Epidemiologic data support 
the existence of an association between different inflamma-
tory markers and high blood pressure.64,65
The normal functional integrity of ECs is maintained 
by continuous cell regeneration and the incorporation of 
endothelial progenitor cells. Under these normal quiescent 
conditions, EC activation tends to be localized, low-grade, 
and reversible. The level of circulating EMP is very low 
when ECs are quiescent.66 The exposure of the endothelium 
to cytokines causes vascular inflammation by inducing EC 
activation and apoptosis. There is a tendency for African 
Americans to have heightened systemic inflammation as mea-
sured by various inflammatory biomarkers.16–21 Long-term 
exposure of the endothelium to proinflammatory cytokines 
leads to increased oxidative stress, inflammation, and apop-
tosis, and promotes leukocyte infiltration and thrombosis. 
All of these changes to ECs cause vascular dysfunction 
and support an EC environment favoring hypertension and 
atherosclerosis.
The aim of this observational study was to assess ECs 
that have not been exposed to chronic diseases in order to 
assess their fundamental response to stimuli. The HUVECs 
were purchased from Lonza Inc in which only the racial 
origin is known, due to The Health Insurance Portability and 
Accountability Act, which protects the privacy of individually 
identifiable health information. HUVECs are derived from 
fetal tissue which makes them better suited for measuring 
fundamental responses to stimuli because adult ECs may 
have been subjected to prolonged exposure to cytokines, hor-
mones, and other stimuli, potentially resulting in an altered 
phenotype.67 An EC obtained from a newborn has already 
developed to the point where it is suitable for its particular 
function. One study found that out of the potentially con-
founding variables such as the interval between delivery and 
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age, smoking habits, diabetes, or hypertension of the mother, 
only the short time between delivery and cell isolation and 
the mother’s smoking habits lead to alterations in cell culture 
success rate68 and morphology.69 Thus while we do not know 
the specific characteristics of the mothers, we believe that the 
HUVECs were relatively unaffected by the mother.
There are several limitations of the study that are worth 
noting. First, we did not directly measure the levels of the 
superoxide radical. The measurement of total SOD activ-
ity provides insight into the cell’s potential for superoxide 
  quenching. Second, we only incubated the cells with TNF-α 
for 4 hours. This was done in order to avoid significant 
  apoptosis. Lastly, the present observational study cannot 
provide insight into potential mechanisms for heightened EC 
susceptibility to TNF-α in AA HUVECs but it may lie in dif-
ferences in TNF-α receptor sensitivity and/or post-receptor 
signaling mechanisms.
The preliminary results of our study suggest that AA 
HUVECs are more susceptible to the injurious effects of the 
proinflammatory cytokine, TNF-α. In addition, the results 
suggest that TNF-α-induced oxidative stress plays a greater 
role in EMP generation in AA compared to Caucasian 
HUVECs. If African Americans tend to have a subclinical 
heightened state of chronic systemic low-grade inflammation, 
then the manner in which their ECs respond to inflammatory 
cytokines could make them more susceptible to long-term 
endothelial dysfunction and its sequelae such as hyperten-
sion and atherosclerosis. This warrants the importance of 
aggressive preventive lifestyle modification strategies in 
African Americans in early subclinical stages of hyperten-
sion development to reduce the inflammation and oxidative 
stress burdens.
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